DIA/FDA Oligonucleotide-based Therapeutic Conference 2015

Published: 6-Aug-2015

9 - 11 September 2015

Conference

Washington, DC, US


For the sixth time in eight years, DIA and FDA have convened industry and health authorities to inform, educate, and share developmental advances, safety, and challenges in the field in oligonucleotide-based therapeutics. This conference will include three tracks: non-clinical; clinical development; and chemistry, manufacturing, and controls (CMC).

Organiser: DIA (Drug Information Association)

Trending Articles

  1. CPhI North America 7-9 May 2024 | Exhibition | Pennsylvania, US
  2. Cleanroom Conference UK 22–23 May 2024 | Exhibition | Birmingham, UK
  3. ASGCT Annual Meeting 2024 7-11 May, 2024 | Meeting | Portland, OR
  4. POWTECH 23-25 September 2025 | Exhibition | Nuremberg, Germany
  5. Pharmaconex 8-10 September 2024 | Conference | Cairo, Egypt

You may also like

Regulatory

Biosimilars 2015

19 - 20 October 2015, Meeting, Bethesda, MD, US
Research & Development

DIA/FDA Oligonucleotide-based Therapeutic Conference 2015

9 - 11 September 2015, Conference, Washington, DC, US
Research & Development

DIA 2015

14 - 18 June 2015, Annual Meeting, Washington, DC, US
Research & Development

CMC Workshop: Translating Science into Successful Regulatory Submissions

<b>7 - 9 February 2011</b><br> Washington, DC, US
Regulatory

Advancing Pediatric Research in the US

<b>12 - 13 October 2010</b><br> Bethesda, Maryland, US
Research & Development

DIA 4th Annual Clinical Forum

<b>11 - 13 October 2010</b><br> Lisbon, Portugal
Subscribe now